
Clinical Trial Sites
We are currently engaged in or have completed clinical trials in cooperation with the following medical centers:
Spinal Cord Injury
- Balgrist University Hospital, University of Zurich
- StemCells is conducting a Phase I/II clinical trial of HuCNS-SC cells in Switzerland at the Balgrist University Hospital, University of Zurich, one of the leading medical centers in the world for spinal cord injury and rehabilitation. The principal investigator is Armin Curt, MD, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich, and Medical Director of the Paraplegic Center at the Balgrist University Hospital. Dr. Curt is an internationally renowned medical expert in spinal cord injury. The trial was initiated in March 2011, and is currently open for enrollment.
PMD
- UCSF Children’s Hospital
- StemCells is conducting a Phase I clinical trial of HuCNS-SC cells in PMD at the University of California, San Francisco (UCSF) Children’s Hospital in collaboration with Principal Investigator David H. Rowitch, MD, PhD, chief of Neonatology, professor of Pediatrics and Neurological Surgery, member of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, and a Howard Hughes Medical Institute investigator; and Co-investigators Nalin Gupta, MD, PhD, chief of Pediatric Neurological Surgery and Jonathan B. Strober, MD, director of Clinical Services for Child Neurology and director of the Muscular Dystrophy Clinic.
NCL
- OHSU Doernbecher Children’s Hospital
-
StemCells has completed a Phase I clinical trial of HuCNS-SC cells in NCL at Oregon Health & Science University (OHSU) Doernbecher Children’s Hospital in collaboration with Principal Investigators Robert Steiner, M.D., FAAP, FACMG, professor of Pediatrics and Molecular and Medical Genetics, and vice chairman for Pediatric Research, and Nathan Selden, M.D., Ph.D., FACS, FAAP, Campagna Professor of Pediatric Neurosurgery and head of the Division of Pediatric Neurological Surgery at OHSU Doernbecher Children’s Hospital and OHSU School of Medicine.
